Cannabis M&A Lawyer

Cannabis business mergers and acquisitions (M&A) carry greater regulatory risk than standard transactions, affecting deal structures, valuations and future operations.

Speak to a cannabis M&A lawyer at Kight Law to assess your legal risk and make more informed decisions.

Our Cannabis M&A Legal Services

Most mergers and acquisitions within the hemp and cannabis sector depend on whether licenses, ownership structures, product lines and supply chain relationships remain compliant after a change in control.

At Kight Law, we advise cannabis businesses on key legal considerations, including:

  • Transaction structure: Assessing how legal and regulatory issues may affect the way a deal is structured
  • Due diligence: Reviewing licensing, compliance, contracts and operational risk before a transaction moves forward
  • Ownership changes: Understanding how ownership, control or management changes may affect licensed cannabis operations
  • Market and product risk: Evaluating how state-by-state rules and product classification affect deal value and future operations
  • Commercial agreements: Reviewing contracts, supply chain relationships and other obligations that may affect the transaction

Why Work with Rod Kight

Rod Kight advises cannabis, hemp and cannabinoid businesses on complex legal and regulatory issues across the US and internationally.

Why Rod?

Contact Rod Kight

Contact Rod Kight

First
Last

Experience and Services

Kight Law advises cannabis and hemp businesses on how legal and regulatory issues can affect transactions, ownership changes and commercial risk.

This includes assessing how licenses, compliance obligations, contracts and product classification may influence deal structure, diligence findings and post-closing operations.

By connecting transaction strategy with cannabis-specific legal risk, we help businesses make more informed decisions before buying, selling, merging with or investing in a cannabis business.

Speak to a cannabis M&A lawyer about your next move.

The DEA discussed THCA in a recent letter.

Cannabis Business Law Articles

 

Want to Read the Latest Edition of the American Journal of Endocannabinoid Medicine?

By Rod Kight | March 31, 2020
The American Journal of Endocannabinoid Medicine (AJEM) is the only printed, peer-reviewed, medical cannabis journal in North America. AJEM’s mission is to create, collect, and disseminate credible cannabis research data.

Are Oregon Cannabis Dispensaries Offering an Essential Service?

By Rod Kight | March 27, 2020
If cannabis stores close, the state of Oregon would be depriving many patients who rely on retail cannabis stores access to their medicine. If retail cannabis stores remain open, does it make sense to limit access to medicinal patents?

Hemp Trademarking- Why You Cannot Own a Varietal Name

By Rod Kight | March 25, 2020
Trademark registration is not simply a matter of racing to the USPTO to register a word or phrase that you wish to have exclusive rights to, even if you were the first to use the word or phrase.

Concerned About Coronavirus and Your Cannabis Business? We’d Like to Help.

By Rod Kight | March 19, 2020
As a service to our current clients and readers during these difficult times, we are offering a free 20-minute phone call to address your pressing issues – no strings attached.

our cannabis law services

Farming & Production

Growers & Producers

Products

Processors & Manufacturers

Providers

Distributors & Retailers

Pharmaceuticals

Science & Medicine

Honors & Recognitions